BRPI1014888A2 - piperazinil azetidinil amidas heteroaromáticas e aromáticas como inibidores de monoacilglicerol lipase - Google Patents
piperazinil azetidinil amidas heteroaromáticas e aromáticas como inibidores de monoacilglicerol lipaseInfo
- Publication number
- BRPI1014888A2 BRPI1014888A2 BRPI1014888A BRPI1014888A BRPI1014888A2 BR PI1014888 A2 BRPI1014888 A2 BR PI1014888A2 BR PI1014888 A BRPI1014888 A BR PI1014888A BR PI1014888 A BRPI1014888 A BR PI1014888A BR PI1014888 A2 BRPI1014888 A2 BR PI1014888A2
- Authority
- BR
- Brazil
- Prior art keywords
- heteroaromatic
- lipase inhibitors
- aromatic amides
- monoacylglycerol lipase
- azetidinyl
- Prior art date
Links
- 229940127470 Lipase Inhibitors Drugs 0.000 title 1
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 title 1
- 108020002334 Monoacylglycerol lipase Proteins 0.000 title 1
- 150000008430 aromatic amides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17166009P | 2009-04-22 | 2009-04-22 | |
| PCT/US2010/032098 WO2010124121A1 (en) | 2009-04-22 | 2010-04-22 | Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1014888A2 true BRPI1014888A2 (pt) | 2019-09-24 |
Family
ID=42224827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014888A BRPI1014888A2 (pt) | 2009-04-22 | 2010-04-22 | piperazinil azetidinil amidas heteroaromáticas e aromáticas como inibidores de monoacilglicerol lipase |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8815839B2 (pt) |
| EP (1) | EP2421852B9 (pt) |
| JP (1) | JP2012524809A (pt) |
| KR (1) | KR20120014154A (pt) |
| CN (1) | CN102548983B (pt) |
| AR (1) | AR076375A1 (pt) |
| AU (1) | AU2010238745A1 (pt) |
| BR (1) | BRPI1014888A2 (pt) |
| CA (1) | CA2759714A1 (pt) |
| DK (1) | DK2421852T3 (pt) |
| ES (1) | ES2486674T3 (pt) |
| IL (1) | IL215796A (pt) |
| PT (1) | PT2421852E (pt) |
| RU (1) | RU2558141C2 (pt) |
| TW (1) | TWI495637B (pt) |
| WO (1) | WO2010124121A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2759547A1 (en) | 2009-04-22 | 2010-10-28 | Janssen Pharmaceutica Nv | Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| CN103068798A (zh) | 2010-09-03 | 2013-04-24 | 詹森药业有限公司 | 作为单酰甘油脂肪酶抑制剂的二-氮杂环丁烷二酰胺 |
| WO2012044613A1 (en) * | 2010-09-27 | 2012-04-05 | Janssen Pharmaceutica Nv | Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
| US8513423B2 (en) | 2010-10-22 | 2013-08-20 | Janssen Pharmaceutica, Nv | Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors |
| KR20130140020A (ko) | 2010-10-22 | 2013-12-23 | 얀센 파마슈티카 엔.브이. | 모노아실글리세롤 리파아제 억제제로서의 아미노-피롤리딘-아제티딘 다이아미드 |
| JP6454349B2 (ja) * | 2013-12-26 | 2019-01-16 | 武田薬品工業株式会社 | モノアシルグリセロールリパーゼ（ｍａｇｌ）阻害剤としての４−（ピペラジン−１−イル）−ピロリジン−２−オン化合物 |
| US10045979B2 (en) | 2014-05-19 | 2018-08-14 | Merial Inc. | Anthelmintic compounds |
| EP3279191B1 (en) | 2015-03-30 | 2020-09-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US11273167B2 (en) | 2015-08-03 | 2022-03-15 | The Regents Of The University Of California | Compositions and methods for modulating ABHD2 activity |
| US10463753B2 (en) | 2016-02-19 | 2019-11-05 | Lundbeck La Jolla Research Center, Inc. | Radiolabeled monoacylglycerol lipase occupancy probe |
| JP6832342B2 (ja) | 2016-03-31 | 2021-02-24 | 武田薬品工業株式会社 | 複素環化合物 |
| EA036637B1 (ru) | 2016-03-31 | 2020-12-02 | Такеда Фармасьютикал Компани Лимитед | Гетероциклические спиросоединения, ингибирующие моноацилглицерин-липазу |
| EP3689879B1 (en) | 2017-09-29 | 2025-02-12 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EP3883936B1 (en) | 2018-11-22 | 2023-07-12 | F. Hoffmann-La Roche AG | New heterocyclic compounds |
| US12577217B2 (en) * | 2019-01-08 | 2026-03-17 | Kyorin Pharmaceutical Co., Ltd. | 15-PGDH inhibitor |
| JP7532385B2 (ja) | 2019-01-31 | 2024-08-13 | 杏林製薬株式会社 | １５－ｐｇｄｈ阻害薬 |
| CA3242372A1 (en) | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Inhibiting monoacylglycerol lipase (magl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020507A1 (es) * | 2000-10-17 | 2002-06-25 | Schering Corp | Compuestos no-imidazoles como antagonistas del receptor histamina h3 |
| ES2282731T3 (es) * | 2002-12-23 | 2007-10-16 | Janssen Pharmaceutica N.V. | Derivados de 1-piperidin-4-il-4-azetidin-3-il-piperazina sustituida y su uso como antagonistas de neuroquininas. |
| EP1702916A1 (en) * | 2005-03-18 | 2006-09-20 | Santhera Pharmaceuticals (Schweiz) GmbH | DPP-IV inhibitors |
| FR2915199B1 (fr) * | 2007-04-18 | 2010-01-22 | Sanofi Aventis | Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique. |
| EP2283127B1 (en) * | 2008-04-25 | 2015-04-08 | Janssen Pharmaceutica, N.V. | Protein engineering of monoacylglycerol lipase (mgll) |
| EP2283126A1 (en) * | 2008-04-25 | 2011-02-16 | Janssen Pharmaceutica, N.V. | Crystal structure of monoacylglycerol lipase (mgll) |
| EP2180048B1 (en) * | 2008-10-09 | 2014-12-17 | Janssen Pharmaceutica N.V. | Alternative crystal form of monoacylglycerol lipase (MGLL) |
| US8435977B2 (en) * | 2009-04-22 | 2013-05-07 | Janssen Pharmaceutica, Nv | Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
-
2010
- 2010-04-22 CA CA2759714A patent/CA2759714A1/en not_active Abandoned
- 2010-04-22 JP JP2012507394A patent/JP2012524809A/ja active Pending
- 2010-04-22 BR BRPI1014888A patent/BRPI1014888A2/pt not_active IP Right Cessation
- 2010-04-22 TW TW099112744A patent/TWI495637B/zh not_active IP Right Cessation
- 2010-04-22 AR ARP100101336A patent/AR076375A1/es not_active Application Discontinuation
- 2010-04-22 AU AU2010238745A patent/AU2010238745A1/en not_active Abandoned
- 2010-04-22 CN CN201080028748.2A patent/CN102548983B/zh not_active Expired - Fee Related
- 2010-04-22 ES ES10719479.7T patent/ES2486674T3/es active Active
- 2010-04-22 KR KR1020117027425A patent/KR20120014154A/ko not_active Ceased
- 2010-04-22 WO PCT/US2010/032098 patent/WO2010124121A1/en not_active Ceased
- 2010-04-22 PT PT107194797T patent/PT2421852E/pt unknown
- 2010-04-22 RU RU2011147203/04A patent/RU2558141C2/ru not_active IP Right Cessation
- 2010-04-22 DK DK10719479.7T patent/DK2421852T3/da active
- 2010-04-22 EP EP10719479.7A patent/EP2421852B9/en active Active
-
2011
- 2011-10-23 IL IL215796A patent/IL215796A/en not_active IP Right Cessation
-
2013
- 2013-03-04 US US13/784,036 patent/US8815839B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2421852B1 (en) | 2014-05-21 |
| US20130184251A1 (en) | 2013-07-18 |
| AU2010238745A1 (en) | 2011-11-10 |
| CN102548983B (zh) | 2014-09-17 |
| CN102548983A (zh) | 2012-07-04 |
| WO2010124121A1 (en) | 2010-10-28 |
| AR076375A1 (es) | 2011-06-08 |
| WO2010124121A8 (en) | 2012-03-08 |
| EP2421852B9 (en) | 2015-07-01 |
| CA2759714A1 (en) | 2010-10-28 |
| RU2558141C2 (ru) | 2015-07-27 |
| US8815839B2 (en) | 2014-08-26 |
| IL215796A0 (en) | 2012-01-31 |
| IL215796A (en) | 2015-04-30 |
| HK1166794A1 (en) | 2012-11-09 |
| EP2421852A1 (en) | 2012-02-29 |
| RU2011147203A (ru) | 2013-05-27 |
| ES2486674T3 (es) | 2014-08-19 |
| PT2421852E (pt) | 2014-07-31 |
| KR20120014154A (ko) | 2012-02-16 |
| TW201103917A (en) | 2011-02-01 |
| JP2012524809A (ja) | 2012-10-18 |
| TWI495637B (zh) | 2015-08-11 |
| HK1170239A1 (en) | 2013-02-22 |
| DK2421852T3 (da) | 2014-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1014888A2 (pt) | piperazinil azetidinil amidas heteroaromáticas e aromáticas como inibidores de monoacilglicerol lipase | |
| BRPI1014874A2 (pt) | piperazinil azetidinil amidas heteroaromáticas e aromáticas como inibidores de monoacilglicerol lipase | |
| BRPI1014281A2 (pt) | azetidinil diamidas como inibidores da monoacilglicerol lipase | |
| IL225769A0 (en) | Piperidine-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors | |
| EP2515946A4 (en) | NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES | |
| BR112012028883A2 (pt) | fornecimento de líquido e método | |
| HRP20190016T1 (hr) | Heterociklički spojevi i njihova upotreba | |
| IL225815A0 (en) | Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors | |
| HRP20160737T1 (hr) | Anti-her3-protutijela i njihove uporabe | |
| ZA201202489B (en) | Novel heterocyclic acrylamides and their use as pharmaceuticals | |
| PT3650125T (pt) | Atomizador de líquidos e métodos | |
| PL2427416T3 (pl) | Podstawione związki aromatyczne i ich zastosowania farmaceutyczne | |
| FI20090142A0 (fi) | Uudet menetelmät ja tuotteet | |
| FI20090357L (fi) | Menetelmä ja järjestely | |
| DE11786796T8 (de) | Antigenpeptid und verwendung davon | |
| AP3650A (en) | Apolipoprotein l-i variants and their use | |
| GB201012950D0 (en) | Stabiliser and assembly | |
| BR112013012843A2 (pt) | composições e métodos para o suprimento de nutriente | |
| FI20105760L (fi) | Menetelmä ja järjestely | |
| EP2535415A4 (en) | MODIFIED XYLANASE NUCLEOTIDE MOLECULES AND THEIR APPLICATIONS | |
| EP2638160A4 (en) | NUCLIONE AND RIBOCAPSIDE | |
| FI20105798L (fi) | Kuljetinrata ja tilajärjestely | |
| DE112011104090A5 (de) | Radfelgengetriebe und Planetenumlaufgetriebe | |
| ES1070486Y (es) | Pale modular y autodesplazable | |
| FI20096360A0 (fi) | Bioliima ja puulevy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |